Oramed Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.06.17	Oramed to Present at the American Diabetes Association 77th Scientific Sessions (PR Newswire)
05.06.17	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Oramed Pharmaceuticals Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (PR Newswire)
18.05.17	Oramed to Present at Conferences Next Week (PR Newswire)
09.05.17	Oramed Granted Canadian Patent for GLP-1 Analog Capsule (PR Newswire)
02.05.17	Oramed Receives Israel Regulatory Approval to Conduct Human Study for New Oral Leptin Capsule (PR Newswire)
04.04.17	Journal of Diabetes Science and Technology Publishes Scientific Paper Authored by Oramed Scientists (PR Newswire)
22.03.17	Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017 (PR Newswire)
21.03.17	Oramed Appoints Dr. Ronald Law as Chief Strategy Officer (PR Newswire)
07.02.17	Oramed to Present at BIO CEO and Investor and Disruptive Growth and Healthcare Conferences (PR Newswire)
29.11.16	Oramed's ORMD-0901 (Oral GLP-1 Analog) Found Safe and Well Tolerated in Phase Ib Study (PR Newswire)
18.05.16	Oramed: Primary Safety & Efficacy Endpoints Met In Phase IIb Oral Insulin Study (RTTNews)
06.04.16	The U.S. Gets 2nd Biosimilar, ORMP Awaits Data This Qtr, PFE Hits Mark In OPAL (RTTNews)
10.02.14	Oramed Submits Protocol To Initiate Phase 2a Trial Of ORMD 0801 - Quick Facts (RTTNews)
30.01.14	Oramed Pharma To Move Forward With FDA Phase 2b Multi-Center Study - Quick Facts (RTTNews)
28.01.14	HRTX Buys Time, ORMP On Watch, KOOL Loses Heat, SUPN On A High, PFE Trials Flop (RTTNews)
03.01.14	A Sigh Of Relief For CTIC, ORMP Rally Continues, Stellar Bio Waiting To Sparkle (RTTNews)
02.01.14	Oramed'PlatformTech In Oral Delivery Of Proteins Gets Patent In Israel,Australia (RTTNews)
23.12.13	ARIA On Resurrection, XON Opens Wallet, NUVA In Work Mode, ORMP's Sweet Tidings (RTTNews)
19.11.13	Oramed Pharma Gets Patent In European Union For Oral Delivery Of Insulin (RTTNews)
03.10.13	Oramed Granted Patents in Japan and Canada for its POD™ Technology for the Oral Delivery of Proteins (PR Newswire)
25.09.13	Oramed to Participate in Barclays' Israel Biotech Corporate Day in Zurich on September 30, 2013 (PR Newswire)
17.09.13	Oramed's Platform Technology In Oral Delivery Of Proteins Gets Patent In Russia (RTTNews)
17.09.13	Oramed's Platform Technology in Oral Delivery of Proteins Receives Patent in Russia (PR Newswire)
10.09.13	Oramed's Platform Technology In Oral Delivery Of Proteins Gets Patent In China (RTTNews)
10.09.13	Oramed Granted Patent in China for its Platform Technology in Oral Delivery of Proteins (PR Newswire)
03.09.13	Oramed Submits Pre-IND Package to FDA for ORMD-0901 (oral exenatide), an Oral GLP-1 Analog for the Treatment of Type 2 Diabetes (PR Newswire)
22.08.13	Incyte Excites, ADMP Entitled To Patent, BSX Gets Two Thumbs Up, ORMP On Watch (RTTNews)
21.08.13	Oramed Initiates Patient Recruitment for a New Clinical Trial in Israel of its Oral Insulin Drug ORMD-0801 in the Treatment of Type 1 Diabetes (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	122.05	2.95 %	K V
Lonza Grp	529.20	1.50 %	K V
UBS Group	28.57	0.95 %	K V
Part Grp Hldg	1’274.00	0.83 %	K V
Nestle	76.62	0.82 %	K V
Swisscom	506.50	-0.59 %	K V
Zurich Insur Gr	549.60	-0.61 %	K V
Sonova Hldg	309.20	-0.93 %	K V
Swiss Life Hldg	725.80	-1.06 %	K V
Novartis	92.37	-1.40 %	K V

Nachrichten zu Oramed Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten